Arbutus Biopharma Corporation (ABUS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.34
Day's range
$4.8

Arbutus Biopharma Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MORGAN STANLEY 02/13/2026 26.70 M $128.44 M   9.21% 13.92%
WHITEFORT CAPITAL MANAGEMENT, LP 02/17/2026 13.34 M $64.18 M   0.00% 6.96%
BLACKROCK, INC. 02/12/2026 13.05 M $62.78 M   2.96% 6.81%
TWO SEAS CAPITAL LP 02/11/2026 12.59 M $60.55 M   14.54% 6.56%
VANGUARD GROUP INC 01/29/2026 9.24 M $44.46 M   2.80% 4.82%
STATE STREET CORP 02/13/2026 5.91 M $28.42 M   44.16% 3.08%
ADAR1 CAPITAL MANAGEMENT, LLC 02/18/2026 5.42 M $26.05 M   86.52% 2.82%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/17/2026 4.34 M $20.88 M   -13.46% 2.26%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 3.68 M $17.69 M   0.30% 1.92%
WOODLINE PARTNERS LP 02/17/2026 2.19 M $10.52 M   0.97% 1.14%
BLACKBARN CAPITAL PARTNERS LP 02/17/2026 1.85 M $8.90 M   -7.50% 0.96%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.83 M $8.82 M   26.32% 0.96%
RUBRIC CAPITAL MANAGEMENT LP 02/13/2026 1.58 M $7.58 M   0.00% 0.82%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.56 M $7.51 M   22.55% 0.81%
ADVISOR GROUP HOLDINGS, INC. 02/17/2026 1.35 M $6.48 M   0.73% 0.70%
NORTHERN TRUST CORP 02/17/2026 1.24 M $5.95 M   -4.09% 0.64%
STEMPOINT CAPITAL LP 02/17/2026 986.75 K $4.75 M   380.43% 0.51%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 890.90 K $4.29 M   100.00% 0.46%
RANGELEY CAPITAL, LLC 02/17/2026 840.00 K $4.04 M   0.00% 0.44%
BANK OF MONTREAL /CAN/ 02/12/2026 766.66 K $3.69 M   0.18% 0.40%
GOLDMAN SACHS GROUP INC 03/25/2026 738.58 K $3.55 M   -66.02% 0.39%
HUDSON BAY CAPITAL MANAGEMENT LP 02/13/2026 675.00 K $3.25 M   -15.63% 0.35%
CITIGROUP INC 02/13/2026 620.00 K $2.98 M   -26.63% 0.32%
CITIGROUP INC 02/13/2026 611.15 K $2.94 M   208.91% 0.32%
DIADEMA PARTNERS LP 02/17/2026 548.60 K $2.64 M   6.26% 0.29%
AFFINITY ASSET ADVISORS, LLC 02/13/2026 521.90 K $2.51 M   146.76% 0.27%
QUINN OPPORTUNITY PARTNERS LLC 02/13/2026 514.51 K $2.47 M   0.00% 0.27%
WESTERN STANDARD LLC 02/03/2026 507.85 K $2.44 M   0.00% 0.26%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 505.09 K $2.43 M   0.00% 0.26%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 474.36 K $2.28 M   -7.73% 0.25%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 473.60 K $2.28 M   27.28% 0.25%
FREESTONE CAPITAL HOLDINGS, LLC 01/23/2026 442.50 K $2.13 M   0.00% 0.23%
BANK OF NEW YORK MELLON CORP 02/10/2026 387.91 K $1.87 M   -2.81% 0.20%
BARCLAYS PLC 02/13/2026 356.68 K $1.72 M   25.45% 0.19%
SABA CAPITAL MANAGEMENT, L.P. 02/17/2026 347.89 K $1.67 M   -48.75% 0.18%
CITIGROUP INC 02/13/2026 339.20 K $1.63 M   -22.77% 0.18%
SWISS NATIONAL BANK 02/12/2026 283.40 K $1.36 M   2.57% 0.15%
LEDGEWOOD WEALTH ADVISORS, LLC 01/16/2026 278.44 K $1.34 M   0.00% 0.15%
MURCHINSON LTD. 02/17/2026 275.00 K $1.32 M   37.50% 0.14%
NUVEEN, LLC 02/12/2026 257.93 K $1.24 M   0.00% 0.13%
INVESCO LTD. 02/19/2026 247.25 K $1.19 M   17.94% 0.13%
D. E. SHAW & CO., INC. 02/17/2026 231.76 K $1.11 M   22.01% 0.12%
MURCHINSON LTD. 02/17/2026 222.90 K $1.07 M   0.00% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 192.20 K $924.48 K   628.03% 0.10%
RHUMBLINE ADVISERS 02/13/2026 183.25 K $881.42 K   -13.47% 0.10%
WELLS FARGO & COMPANY/MN 02/13/2026 167.02 K $803.37 K   74.98% 0.09%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 157.58 K $757.95 K   -26.72% 0.08%
NOMURA HOLDINGS INC 02/17/2026 150.00 K $721.50 K   0.00% 0.08%
UBS GROUP AG 01/29/2026 147.29 K $708.48 K   -80.98% 0.08%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 02/17/2026 144.11 K $693.17 K   9.62% 0.08%

Arbutus Biopharma Corp institutional Ownership - FAQ's

During the previous two years, 231 institutional investors and hedge funds held shares of Arbutus Biopharma Corp. The most heavily invested institutionals were:

Legal & General Group Plc: 2.4 M

Jefferies Financial Group Inc.: 1.89 M

VANGUARD FIDUCIARY TRUST CO: 1.06 M

CITIGROUP INC: 898,421

Western Standard LLC: 521,587

Bank of New York Mellon Corp: 379,373

63.63% of Arbutus Biopharma Corp stock is owned by institutional investors.

Institutional investors have bought a total of 143.36 M shares in the last 24 months. This purchase volume represents approximately $676.68 M in transactions.